




Searching News Database: Transition Therapeutics
HSMN NewsFeed - 9 Dec 2011
Transition Therapeutics Announces the Departure of Its President and Chief Financial Officer
Transition Therapeutics Announces the Departure of Its President and Chief Financial Officer
HSMN NewsFeed - 17 Dec 2009
ImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality
ImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality
HSMN NewsFeed - 13 Mar 2008
Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
HSMN NewsFeed - 28 Dec 2007
Transition Therapeutics Announces Appointment of Vice-President of Business Development
Transition Therapeutics Announces Appointment of Vice-President of Business Development
HSMN NewsFeed - 3 Apr 2007
FDA Grants Fast Track Designation to Alzheimer's Disease Drug Candidate AZD-103/ELND005
FDA Grants Fast Track Designation to Alzheimer's Disease Drug Candidate AZD-103/ELND005
HSMN NewsFeed - 12 Sep 2006
Transition Therapeutics Appoints Andre Uddin B.Sc., Ph.D. as Vice-President of Strategic Development
Transition Therapeutics Appoints Andre Uddin B.Sc., Ph.D. as Vice-President of Strategic Development
HSMN NewsFeed - 1 Aug 2006
FDA Provides Clearance to Initiate Phase I Clinical Trial with Alzheimer's Disease Drug Product AZD-103
FDA Provides Clearance to Initiate Phase I Clinical Trial with Alzheimer's Disease Drug Product AZD-103
Additional items found! 9

Members Archive contains
9 additional stories matching:
Transition Therapeutics
(Password required)
Transition Therapeutics
(Password required)